In addition to the slightly higher mean sMMSE score, the considerably higher BDNF levels of the patients on DPP-4 inhibitor treatment suggest that the DPP-4 inhibitors may have protective effects against cognitive impairment. This evidence concerns the gene BDNF and Cognitive impairment.